Parkman Healthcare Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $40M | Sell |
|
|||||
|
2025
Q2 | $30.1M | Buy |
|
|||||
|
2025
Q1 | $18.6M | Buy |
|
|||||
|
2024
Q4 | $9.1M | Buy |
|
|||||
|
2024
Q3 | $7.01M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $2.18M | Sell |
|
|||||
|
2022
Q2 | $3.02M | Sell |
|
|||||
|
2022
Q1 | $8.82M | Sell |
|
|||||
|
2021
Q4 | $9.78M | Sell |
|
|||||
|
2021
Q3 | $14.2M | Hold |
|
|||||
|
2021
Q2 | $12.7M | Buy |
|
|||||
|
2021
Q1 | $9.18M | Buy |
|
|||||
|
2020
Q4 | $4.7M | Buy |
|
|||||
|
2020
Q3 | $4.49M | Sell |
|
|||||
|
2020
Q2 | $5.31M | Sell |
|
|||||
|
2020
Q1 | $3.96M | Buy |
|
|||||
|
2019
Q4 | $4.03M | Buy |
|